Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He will not talk specifics about partnership. He will mention CDA. He will say there is a lot of interest. BP is waiting for completion of phase 2
They earn every dime. When the stock is $10 by year end people will be saying they were underpaid
Where do you get this info. He was brought aboard for his contacts and knowledge about how to structure these trials
The F.D.A. Pays entry level MD's about $225,000 plus big benefits. $420 is not a lot of money
Anothe ridiculous comment
Or just maybe someone wanted 50k shs and didn't mind paying up a few pennies
Probably a good article out or coming out. Leo doesn't hold anything back. He is not bashful about doing a PR if he has something
Ridiculous. They could make bigger salaries elsewhere.
My brother graduated high school with Leslie Stahl but I'm sure they haven't communicated in over 50 years. She is 75
I think also the Boston Business Journal
Email Leo with the info
Agree. They are in for the big payday
Look at the volume. They can't sell the shares without affecting the selling price
Those shares are fully registered with no restrictions
Absolutely agree.
Celgene is not the right partner. They have too much invested in competing products. We want a partner who is fresh in the area
A buyout would not surprise me. Menon is in it for a Nobel Prize.
I could see a deal like this. Sell the company and the stockholders get cash plus shares in a Newco that holds K plus all the untested molecules. Gives BP P & B. Gives us capital gains treatment plus the future of K and the untested stuff. Win win
I believe they have disclosed that BP input was used to structure the trials
I would think they have had offers but they know the value is much higher once phase 2 is completed
AF being invited to the conference this week gives him credibility unfortunately
This whole conversation is too funny.
Then we agree
I believe that is true
Maybe these investors wanted to accumulate a large amount of stock and they couldn't do it in the marketplace. They approach Leo and he likes the idea.
As for selling this same logic holds. They can't be flippers. The market can't absorb those shares very easily
I believe they own a lot. They believe in the science. They keep their holdings below level to report
Don't expect any movement from this presentation
Maybe Aspire was part of the $2.2 million. We don't know who they are
Why don't you give them Leo's email
How about they know the science and that Leo has stated publicly that his goal is a partnership this year
Where did it say the investors went to Leo
I think a number of posts speculating that friends or business associates bought the offering because of inside information is just wrong. Leo and Art would not put themselves in that kind of position. It's illegal.
Maybe they are just regular investors with deep pockets who wanted more stock
Maybe they are biotech funds dipping their toe in the water
Aspire is still active. At last count $19 million left
Read it completely
No warrants
Ridiculous
Coincidence
That thinking doesn't deserve a reply
Outright sale incurs a large income tax. If Leo gets a huge offer for P and B then sell the whole company then maybe get K back as a separate company. Capital gain. Much better